LQDA
Liquidia Technologies Inc
NASDAQ: LQDA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$45.72
+0.62% today
Updated 2026-10-28
Market cap
$3.07B
P/E ratio
24.71
P/S ratio
6.82x
EPS (TTM)
$1.39
Dividend yield
—
52W range
$22 – $94
Volume
3.8M
Liquidia Technologies Inc (LQDA) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$45.72
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.2B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 24.71x (capped 25x) · Margin: 30.70%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.